Sign in →

Test ID FFCAH Congenital Adrenal Hyperplasia (CAH) Pediatric Profile 6, Comprehensive Screen


Specimen Required


Collection Container/Tube: Red top (serum gel/SST are not acceptable)

Submission Container/Tube: Plastic vial

Specimen Volume: 3.5 mL Serum

Collection Instructions:

1. Within 45 minutes of collection, centrifuge and aliquot serum into a plastic vial.

2. Send frozen.

Additional Information: To avoid delays in turnaround time when requesting multiple tests, submit separate frozen specimens for each test requested.


Method Name

High Pressure Liquid Chromatography/Tandem Mass Spectrometry (HPLC/MS-MS)

Reporting Name

CAH Profile 6

Specimen Type

Serum Red

Specimen Minimum Volume

Serum: 2 mL Note: This volume does not allow for repeat testing.

Specimen Stability Information

Specimen Type Temperature Time
Serum Red Frozen 90 days

Reference Values

Androstenedione:

Premature (26-28 weeks) Day 4: 63-935 ng/dL

Premature (31-35 weeks) Day 4: 50-449 ng/dL

Full Term (1-7 days): <10-279 ng/dL

Levels decrease rapidly to <52 ng/dL after one week.

1 month-11 months: <10-37 ng/dL

Androstenedione gradually decreases during the first six months to prepubertal levels.

Prepubertal Children: <10-17 ng/dL

Adults

Males: 44-186 ng/dL

Females: 2 -230 ng/dL

Females Postmenopausal: <10-93 ng/dL

 

Cortisol:

Premature (26-28 weeks) Day 4: 1.0-11 ug/dL

Premature (31-35 weeks) Day 4: 2.5-9.1 ug/dL

Full Term Day 3: 1.7-14 ug/dL

Full Term Day 7: 2.0-11 ug/dL

31 days-11 months: 2.8-23 ug/dL

12 months-15 years (8 a.m.): 3.0-21 ug/dL

Adults

8 a.m.: 8.0-19 ug/dL

4 p.m.: 4.0-11 ug/dL

 

Deoxycorticosterone (DOC):

Premature (26-28 weeks) Day 4: 20-105 ng/dL

Premature (34-36 weeks) Day 4: 28-78 ng/dLNewborn: Levels are markedly elevated at birth and decrease rapidly during the first week to the range of 7-49 ng/dL as found in older infants.

1 month-11 months: 7-49 ng/dL

Prepubertal Children: 2-34 ng/dL

Pubertal Children and Adults 8 a.m.: 2-19 ng/dL

 

Dehydroepiandrosterone (DHEA):

Premature (26-31 weeks): 82-1484 ng/dL

Premature (32-35 weeks): 56-1853 ng/dL

Full Term (2-7 days): 41-1292 ng/dL

8 days-5 months: <948 ng/dL

6 months-12 months: <136 ng/dL

1 year-5 years: <68 ng/dL

6-7 years: <111 ng/dL

8-10 years: <186 ng/dL

11-12 years: <202 ng/dL

13-14 years: <319 ng/dL

15-16 years: 39-481 ng/dL

17-19 years: 40-491 ng/dL

20-50 years: 31-701 ng/dL

>50 years: 21-402 ng/dL

 

11-Desoxycortisol:

Premature (26-28 weeks) Day 4: 110-1376 ng/dL

Premature (31-35 weeks) Day 4: 48-579 ng/dL

Full term Newborn Day 3: 13-147 ng/dL

1 month-11 months: <10-156 ng/dL

Prepubertal 8 a.m.: 20-155 ng/dL

Pubertal Children and Adults 8 a.m.: 12-158 ng/dL

 

17-OH Pregnenolone:

Premature (26-28 weeks) Day 4: 375-3559 ng/dL

Premature (31-35 weeks) Day 4: 64-2380 ng/dL

3 days: 10-829 ng/dL

1 month-5 months: 36-763 ng/dL

6-11 months: 42-540 ng/dL

12-23 months: 14-207 ng/dL

24 months-5 years: 10-103 ng/dL

6-9 years: 10-186 ng/dL

Pubertal: 44-235 ng/dL

Adults: 53-357 ng/dL

 

Progesterone:

Males

1 year-16 years: <10-15 ng/dL

Adults: <10-11 ng/dL

Females

1 year-10 years: <10-26 ng/dL

11 years: <10-255 ng/dL

12 years: <10-856 ng/dL

13 years: <10-693 ng/dL

14 years: <10-1204 ng/dL

15 years: <10-1076 ng/dL

16 years: <10-1294 ng/dL

Adult

Cycle days

1-6: <10-17 ng/dL

7-12: <10-135 ng/dL

13-15: <10-1563 ng/dL

16-28: <10-2555 ng/dL

Post Menopausal: <10 ng/dL

Note: Luteal progesterone peaked from 350 to 3750 ng/dL on days ranging from 17 to 23.

 

17-Alpha-Hydroxyprogesterone (17-OHP):

Premature (26-28 weeks) Day 4: 124-841 ng/dL

Premature (31-35 weeks) Day 4: 26-568 ng/dL

Full-Term Day 3: <78 ng/dL

 

Males:

Levels increase after the first week to peak values ranging from 40-200 ng/dL between 30 and 60 days. Values then decline to a prepubertal value of <91 ng/dL before one year.

Prepubertal: <91 ng/dL

Adult: 27-199 ng/dL

 

Females:

1 month-11 months: 13-106 ng/dL

Prepubertal: <91 ng/dL

Adult:

Follicular: 15-70 ng/dL

Luteal: 35-290 ng/dL

 

Testosterone, Total

Males:

Premature (26-28w) Day 4: 59-125 ng/dL

Premature (31-35w) Day 4: 37-198 ng/dL

Newborns: 75-400 ng/dL

1 month-7 months: Levels decrease rapidly the first week to 20-50 ng/dL, then increase to 60-400 ng/dL between 20 and 60 days. Levels then decline to prepubertal range levels of <2.5-10 ng/dL by seven months.

 

Females:

Premature (26-28w) Day 4: 5-16 ng/dL

Premature (31-35w) Day 4: 5-22 ng/dL

Newborns: 20-64 ng/dL

1 month-7 months: Levels decrease during the first month to less than 10 ng/mL and remain there until puberty.

 

Prepubertal Males and Females: <2.5-10 ng/dL

Adult

Males >18 years: 264-916 ng/dL

Females:

Premenopausal: 10-55 ng/dL

Postmenopausal: 7-40 ng/dL

 

Males

Tanner Stage 1 <9.8 years: <2.5-10 ng/mL

Tanner Stage 2 9.8 years-14.5 years: 18-150 ng/mL

Tanner Stage 3 10.7 years-15.4 years: 100-320 ng/mL

Tanner Stage 4 11.8 years-16.2 years: 200-620 ng/mL

Tanner Stage 5 12.8 years-17.3 years: 350-970 ng/mL

Females

Tanner Stage 1 <9.2 years: <2.5-10 ng/mL

Tanner Stage 2 9.2-13.7 years: 7-28 ng/mL

Tanner Stage 3 10.0-14.4 years: 15-35 ng/mL

Tanner Stage 4 10.7-15.6 years: 13-32 ng/mL

Tanner Stage 5 11.8-18.6 years: 20-38 ng/mL

Day(s) Performed

Monday, Wednesday

Report Available

10 to 19 days

Performing Laboratory

Esoterix Endocrinology

CPT Code Information

82633 - DOC

82634 - 11-Desoxycortisol

82157 - Androstenedione

82533 - Cortisol

82626 - DHEA

84143 - 17-OH-Pregnenolone

84144 - Progesterone

83498 - 17-OH-Progesterone

84403 - Testosterone

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FFCAH CAH Profile 6 Not Provided

 

Result ID Test Result Name Result LOINC Value
Z5043 Cortisol 2143-6
Z5044 Deoxycorticosterone (DOC) 1656-8
Z5045 11-Desoxycortisol 1657-6
Z5046 Dehydroepiandrosterone (DHEA) 2193-1
Z5047 17-OH Pregnenolone 6765-2
Z5048 Progesterone 2839-9
Z5049 17-Alpha-Hydroxyprogesterone 17-OHP 1668-3
Z5050 Androstenedione 1854-9
Z5051 Testosterone, Total 2986-8

Test Classification

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.